CIK 0001815974 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Anebulo Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ANEB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851170950
- Phone
- 737 203 5270
- Business address
- C/O ANEBULO PHARMACEUTICALS, INC., 1017 RANCH ROAD 620 SOUTH, SUITE 107, LAKEWAY, TX, 78734
- UPLOAD Other SEC-generated Letter
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Material agreement · Delisting notice
- S-3 Offering Registration Statement
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Other events
- D Other Notice of Sales of Unregistered Securities
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 10,101,010 shares at $0.99 ($10,000,000)
- 8-K Event Material agreement · Unregistered share sale · Change in control · Other events
- 4 Derivatives Options or other derivatives
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Other events
- 4 Derivatives Options or other derivatives
Page 4 of 11 · 204 filings